Sources Novo Nordisk's Wegovy pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America Novo Nordisk January 5, 2026 Starter Dose of Wegovy now Available as a Daily Pill Instead of Weekly Injection CNN Health January 5, 2026
Reduced-Frequency Maintenance (Wu, Cengiz & Lawley, 2025) Obesity examined patients taking semaglutide or tirzepatide every 24 weeks instead of weekly
But real life on a GLP-1 isnt always ideal, especially early on, when your appetite drops, or when the side effects interfere with eating
@therealebjohnson "I hate to be the bearer of bad news, but I hope you guys realize that the more your favorite pop stars continue to take oz epic, the more their stage shows are all going to start to look like Katy Perry's
If you are pregnant, planning pregnancy, or nursing, avoid use until more data becomes available